rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-11-8
|
pubmed:abstractText |
We carried out a model of chronic inflammation using a subcutaneous paraffin tablet in mice experimentally infected with Leishmania major. It was previously reported that the parasite load following paraffin implantation occurred at a peak of 21 days in both BALB/c and C57BL/6 mice. At the present study, we have investigated what cytokines and chemokines are directly related to the parasite load in C57BL/6 mice. All mice were divided in four groups: mice implanted with paraffin tablets; mice experimentally infected with L. major; mice implanted with paraffin tablets and experimentally infected with L. major; and mice submitted only to the surgery were used for the Real-Time Polymerase Chain Reaction (RT-PCR) controls. Fragments of skin tissue and the tissue surrounding the paraffin tablets (inflammatory capsule) were collected for histopathology and RT-PCR studies. By 21 days, a diffuse chronic inflammatory reaction was mainly observed in the deep dermis where macrophages parasitized with Leishmania amastigotes were also found. RT-PCR analysis has shown that BALB/c mice showed strong IL-4 and IL-10 mRNA expression than controls with very little expression of IFN-?. In contrast, both IFN-? and IL-10 mRNA was found in higher levels in C57BL/6 animals. Moreover, in C57BL/6 mice the expression of chemokines mRNA of CCL3/MIP-1? was more highly expressed than CCL2/MCP-1. We conclude that the Th1 immune response C57BL/6 did not change to a Th2 response, even though C57BL/6 animals presented higher parasitism than BALB/c mice 21 days after infection and paraffin implantation.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10338536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10807766,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10859337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10881180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10897418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-10899907,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-11093125,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-11097369,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-11113254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-11145695,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-11865425,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-12102714,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-12415308,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-12447609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-12851642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-1496927,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-15271961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-15275451,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-15357217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-15728505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-16184231,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-16322748,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-16972903,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17088347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17201934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17202371,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17283207,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17471442,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-17568857,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-1833466,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-19029990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-2175327,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-3226313,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-7722408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-8752935,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-9462513,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-9504340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20857143-9782133
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1432-2307
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
457
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
609-18
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading |
pubmed-meshheading:20857143-Animals,
pubmed-meshheading:20857143-Chemokines,
pubmed-meshheading:20857143-Cytokines,
pubmed-meshheading:20857143-Leishmania major,
pubmed-meshheading:20857143-Leishmaniasis, Cutaneous,
pubmed-meshheading:20857143-Mice,
pubmed-meshheading:20857143-Mice, Inbred BALB C,
pubmed-meshheading:20857143-Mice, Inbred C57BL,
pubmed-meshheading:20857143-Paraffin,
pubmed-meshheading:20857143-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20857143-Tablets
|
pubmed:year |
2010
|
pubmed:articleTitle |
Murine immune response induced by Leishmania major during the implantation of paraffin tablets.
|
pubmed:affiliation |
Departamento de Patologia Geral, Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Belo Horizonte, MG, Brazil. marialeticia@ufmg.br
|
pubmed:publicationType |
Journal Article
|